Arkolith/Insider Trading/AXNX/Form 4

Noblett Karen

Chief Medical OfficerAxonics, Inc. (AXNX) · full profile →Form 4 · filed Nov 15, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 15, 2024Disposed to issuer(D)34K$71.00$2.4M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 15, 2024Disposed to issuer(D)6K$45.18$287K0
Nov 15, 2024Disposed to issuer(D)8K—$00
Nov 15, 2024Disposed to issuer(D)3K$56.81$168K0
Nov 15, 2024Disposed to issuer(D)12K$69.37$832K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-007708) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML